Literature DB >> 7899716

Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery.

P Girard1, G Mimoun, I Karpouzas, G Montefiore.   

Abstract

PURPOSE: To identify the clinical risk factors for the development of severe proliferative vitreoretinopathy (PVR) after retinal detachment surgery.
METHODS: A retrospective study of 1020 patients with either no PVR or with PVR of grade C1 or less at initial examination was conducted. After surgery, severe PVR was defined as grade C2 or worse. The data relating to 94 variables were evaluated by univariate analysis and stepwise logistic regression.
RESULTS: Severe PVR developed after surgery in 107 patients (10.5%). Ten significant predictive variables were identified: minor intra- or postoperative hemorrhage, grade A preoperative PVR, preoperative choroidal detachment, giant tears, air tamponade, detachment involving more than 2 quadrants, cumulative break area larger than 3 optic disks, postoperative choroidal detachment, signs of uveitis at initial examination, and grade B preoperative PVR.
CONCLUSION: The results indicate that in addition to the size of breaks, extent of detachment, and presence of preoperative inflammation or low-grade PVR, iatrogenic problems also are important factors in the pathogenesis of severe PVR after surgery for retinal detachment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899716     DOI: 10.1097/00006982-199414050-00005

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  35 in total

1.  Conventional buckling surgery or primary vitrectomy with silicone oil tamponade in rhegmatogenous retinal detachment with multiple breaks.

Authors:  Filiz Afrashi; Tansu Erakgun; Cezmi Akkin; Mahmut Kaskaloglu; Jale Mentes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-09       Impact factor: 3.117

2.  The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR).

Authors:  Khaled Nassar; Julia Lüke; Matthias Lüke; Mahmoud Kamal; Effat Abd El-Nabi; Mahmoud Soliman; Martin Rohrbach; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-07       Impact factor: 3.117

Review 3.  THE PATHOGENY OF PROLIFERATIVE VITREORETINOPATHY.

Authors:  Danielescu Ciprian
Journal:  Rom J Ophthalmol       Date:  2015 Apr-Jun

Review 4.  Astrocyte structural reactivity and plasticity in models of retinal detachment.

Authors:  Gabriel Luna; Patrick W Keeley; Benjamin E Reese; Kenneth A Linberg; Geoffrey P Lewis; Steven K Fisher
Journal:  Exp Eye Res       Date:  2016-04-06       Impact factor: 3.467

Review 5.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

6.  A novel function of p53: a gatekeeper of retinal detachment.

Authors:  Hetian Lei; Marc-Andre Rheaume; Jing Cui; Shizuo Mukai; David Maberley; Arif Samad; Joanne Matsubara; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

7.  Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous.

Authors:  Steven M Couch; Sophie J Bakri
Journal:  Clin Ophthalmol       Date:  2008-12

8.  The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.

Authors:  Ernesto Bali; Eric J Feron; Ed Peperkamp; Marc Veckeneer; Paul G Mulder; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-25       Impact factor: 3.117

9.  The fate of Müller's glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formation.

Authors:  Geoffrey P Lewis; Ethan A Chapin; Gabriel Luna; Kenneth A Linberg; Steven K Fisher
Journal:  Mol Vis       Date:  2010-07-15       Impact factor: 2.367

Review 10.  Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.

Authors:  Hetian Lei; Marc-Andre Rheaume; Andrius Kazlauskas
Journal:  Exp Eye Res       Date:  2009-11-25       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.